We are a fully integrated CDMO service provider, that offers innovative development and manufacturing services and technologies, from early phase drug discovery to market supply, across a broad variety of molecule types.
Leading through biomanufacturing and chemical synthesis.
Mohak Labo Pharma is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological processes while always embracing the highest international safety, quality, and environmental standards. Mohak Labo Pharma is recognized among the prominent API manufacturing companies for its commitment to excellence and innovation in the pharmaceutical industry.